Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04888312
Title Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients (OPTIMIZE-1)
Acronym OPTIMIZE-1
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Alligator Bioscience AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires St-Luc Brussels Belgium Details
Hospital Erasme Bruxelles Belgium Details
UZA Antwerp Edegem Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
Centre Hospitalier Universitaire de Bordeaux - Hôpital Haut-Lévêque, Bordeaux France Details
Centre Lyon Berard Lyon France Details
Institut Paoli-Calmettes Marseille France Details
Hopital Européen Georges Pompidou Paris 75015 France Details
Institute de Cancérologie de Lorraine Vandœuvre-lès-Nancy France Details
Hospital Universitario Vall d'Hebron, Barcelona, Spain Barcelona Spain Details
Hospital Universitario La Paz, Madrid, Spain Madrid Spain Details
Hospital Universitario Ramon y Cajal, Madrid, Spain Madrid Spain Details
Hospital Universitario Virgen del Rocio, Sevilla, Spain Sevilla Spain Details
Hospital Universitario Miguel Servet, Zaragoza, Spain Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field